In a study of 239 women receiving adjuvant chemotherapy for early-stage breast cancer at a single clinic from 2009 to 2011, the FN odds ratio for patients not receiving G-CSF primary prophylaxis (versus those receiving prophylaxis) was 2.6 (p = 0.002) [44]. Here, CSF3 is linked to breast cancer.